Functional restoration of CD56<sup>bright</sup> NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B.

Hepatol Int · 2017 · PMC5606950 · PMID 28639033

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

1 e, g) showed improved CD56 bright NK cell recovery compared with those with higher HBV DNA or lower ALT at baseline, but this did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

In HBV DNA negative patients, total NK cells showed a trend to be higher in subjects with HBeAg seroconversion at week 12, 36, and 48 when compared with those without seroconversion (Fig. 3 a).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.